Clinical trials recruiting for ER-positive Breast Cancer
12
Recruiting trials
30
US states with sites
28
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 4 |
| Massachusetts | 4 |
| Texas | 4 |
| Colorado | 3 |
| Illinois | 3 |
| Minnesota | 3 |
| New York | 3 |
| North Carolina | 3 |
| Pennsylvania | 3 |
| Arizona | 2 |
| California | 2 |
| Iowa | 2 |
Top cities
Houston, Texas 4Aurora, Colorado 3Boston, Massachusetts 3Minneapolis, Minnesota 3Charlotte, North Carolina 2Chicago, Illinois 2Nashville, Tennessee 2New York, New York 2San Francisco, California 2Tampa, Florida 2
Self-screener
Recruiting trials
- DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
- Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
- Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
- PRE-ISPY Phase I/II Oncology Platform Program
- Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- Role of the Immune Environment in Response to Therapy in Breast Cancer
- Supporting Health Including Endocrine Treatment for Long Duration
- To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
- Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Related conditions
Trials recruiting for ER-positive Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239HER2-negative Breast Cancer 57Metastatic breast cancer 131PR-Positive Breast Cancer 3Locally Advanced Breast Cancer 13HER2-positive breast cancer 75HER2 Negative Breast Carcinoma 15Breast Cancer - Female 61Triple-negative breast cancer 138TNBC - Triple-Negative Breast Cancer 35
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for ER-positive Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.